Indications
Rotarix is indicated for the active immunisation of infants aged 6 to 24 weeks for prevention of gastroenteritis due to rotavirus infection. The use of Rotarix should be based on official recommendation.
Composition
- Active substance
- human rotavirus, live attenuated
- International name (INN)
- rotavirus vaccine, live
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rotarix
- Active substance
- human rotavirus, live attenuated
- ATC code
- J07BH01
- Therapeutic area
- Immunization, Rotavirus Infections
- Marketing authorisation holder